Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 200 Total
FLJ - FLJ Group Ltd ADR - Stock Price Chart
TickerFLJ [NASD]
CompanyFLJ Group Ltd ADR
CountryChina
IndustryReal Estate Services
Market Cap4.70MEPS (ttm)19522.27
P/E0.00EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y85.56%
P/S0.07EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own0.27%Inst Own2.59%
Insider Trans0.00%Inst Trans-1.85%
Short Float5.38%Earnings-
Analyst Recom-Target Price-
Avg Volume1.10M52W Range0.37 - 23.60
May-20-24 07:36AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -49.87%
May-01-24 08:12PM FLJ GROUP LIMITED RECEIVES NASDAQ DETERMINATION LETTER ON COMPLIANCE PLAN (PR Newswire)
Apr-09-24 09:00AM FLJ GROUP LIMITED RECEIVES NASDAQ MINIMUM BID PRICE DEFICIENCY NOTICE (PR Newswire)
Feb-21-24 05:00PM FLJ Group Limited Receives NASDAQ Deficiency Notice (GlobeNewswire) -8.23%
Feb-16-24 05:00PM FLJ Group Limited Files Annual Report on Form 20-F for Fiscal Year 2023 (GlobeNewswire) +26.32%
Feb-09-24 08:00AM FLJ Group Limited Amends the Maturity Date of the Promissory Notes (GlobeNewswire)
Dec-29-23 10:35AM Why Is FLJ Group (FLJ) Stock Up 10% Today? (InvestorPlace) +44.93%
Dec-28-23 07:00PM FLJ Group Limited Announces Completion of Acquisition of Alpha Mind Technology Limited and Termination of the Lianlian Acquisition (GlobeNewswire) +15.00%
Dec-22-23 05:00PM FLJ Group Limited Announces Appointment of Directors (GlobeNewswire)
Dec-01-23 05:00PM FLJ Group Limited Announces Plan to Implement ADS Ratio Change (GlobeNewswire) +6.60%
DECT - AllianzIM U.S. Large Cap Buffer10 Dec ETF - Stock Price Chart
TickerDECT [NYSE]
CompanyAllianzIM U.S. Large Cap Buffer10 Dec ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Quant Strat
IndexSPDR S&P 500 ETF Trust
TagsU.S., options, buffer, upside-cap, fixed-period, large-cap, SP500
Sector/Theme Region
Dividend0.45%Active/Passive
Total Holdings5AUM37.47M
Flows% 1M-25.77%Flows% 3M-22.29%
Flows% YTD-26.86%Flows% 1Y
Return% 1Y18.75%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume15.27K52W Range25.35 - 30.60
BLCV - BlackRock Large Cap Value ETF - Stock Price Chart
TickerBLCV [NYSE]
CompanyBlackRock Large Cap Value ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - US Style
Index-
TagsU.S., equity, value, large-cap
Sector/Theme Region
Dividend1.29%Active/Passive
Total Holdings58AUM7.23M
Flows% 1M-0.04%Flows% 3M-4.08%
Flows% YTD-4.11%Flows% 1Y
Return% 1Y-Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume1.52K52W Range24.30 - 31.57
AONC - American Oncology Network Inc - Stock Price Chart
TickerAONC [NASD]
CompanyAmerican Oncology Network Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap17.26MEPS (ttm)-2.76
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.02EPS next 5Y-
P/B-EPS Q/Q-10916.81%
Dividend-Sales Q/Q-
Insider Own66.56%Inst Own2.21%
Insider Trans0.00%Inst Trans10.01%
Short Float0.66%EarningsMay 15/b
Analyst Recom-Target Price-
Avg Volume13.18K52W Range2.63 - 39.60
Today 06:00AM American Oncology Network Announces Voluntary Delisting From Nasdaq (GlobeNewswire) -31.56%
May-20-24 12:53PM AONC Stock Earnings: American Oncology Network Reported Results for Q1 2024 (InvestorPlace) -12.62%
May-16-24 04:30PM American Oncology Network Appoints New Board Member (GlobeNewswire)
May-15-24 04:47PM American Oncology Network, Inc. Announces First Quarter 2024 Financial Results (GlobeNewswire)
08:18AM Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:00AM American Oncology Network Advances Karyogram Segmentation and Increases the Speed to Results with New A.I. Software (GlobeNewswire)
May-14-24 08:10AM American Oncology Network Announces Date Change for First Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
May-03-24 05:30PM American Oncology Network Announces CFO Transition (GlobeNewswire)
Apr-30-24 08:00AM American Oncology Network Announces First Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire) -12.79%
Apr-25-24 08:00AM American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and Nevada (GlobeNewswire) -15.43%
CTXR - Citius Pharmaceuticals Inc - Stock Price Chart
TickerCTXR [NASD, RUT]
CompanyCitius Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap135.94MEPS (ttm)-0.24
P/E-EPS this Y0.00%
Forward P/E75.24EPS next Y104.55%
PEG-EPS past 5Y28.21%
P/S-EPS next 5Y-
P/B1.51EPS Q/Q25.42%
Dividend-Sales Q/Q-
Insider Own7.74%Inst Own15.05%
Insider Trans0.00%Inst Trans-6.74%
Short Float8.66%EarningsMay 14/a
Analyst Recom1.00Target Price4.00
Avg Volume974.83K52W Range0.60 - 1.40
Today 11:42AM Yogi Tea Recalls: Yogi Brand Recalls 900,000 Tea Bags for Pesticide Residue (InvestorPlace) +14.03%
11:20AM VFS Stock Alert: VinFast Plunges on NHTSA Probe (InvestorPlace)
10:58AM Why Is Citius Pharmaceuticals (CTXR) Stock Up 11% Today? (InvestorPlace)
07:00AM Citius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution (PR Newswire)
May-14-24 10:55PM CTXR Stock Earnings: Citius Pharma Meets EPS for Q2 2024 (InvestorPlace)
04:05PM Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update (PR Newswire)
May-10-24 08:30AM Citius Pharmaceuticals to Participate in Upcoming EF Hutton and H.C. Wainwright Investor Conferences (PR Newswire)
Apr-30-24 04:05PM Citius Pharmaceuticals Announces Closing of $15 Million Registered Direct Offering (PR Newswire) +7.85%
Apr-26-24 10:43AM Citius Pharmaceuticals Launches $15 Million Offering (MT Newswires) -9.25%
08:00AM Citius Pharmaceuticals Announces $15 Million Registered Direct Offering (PR Newswire)
SABS - SAB Biotherapeutics Inc - Stock Price Chart
TickerSABS [NASD]
CompanySAB Biotherapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap27.74MEPS (ttm)-5.51
P/E-EPS this Y47.77%
Forward P/E-EPS next Y-9.27%
PEG-EPS past 5Y-
P/S10.67EPS next 5Y-
P/B0.53EPS Q/Q-272.72%
Dividend-Sales Q/Q62.55%
Insider Own18.89%Inst Own36.20%
Insider Trans1.03%Inst Trans40.11%
Short Float0.30%EarningsMay 20/b
Analyst Recom1.00Target Price15.50
Avg Volume12.23K52W Range3.38 - 10.50
Today 09:53AM SABS Stock Earnings: SAB Biotherapeutics Misses EPS for Q1 2024 (InvestorPlace) -12.90%
07:15AM FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics (GlobeNewswire)
May-20-24 05:45PM SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates (GlobeNewswire)
May-06-24 07:15AM SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors (GlobeNewswire)
Apr-16-24 07:15AM SAB Biotherapeutics Provides SAB-142 Trial Update (GlobeNewswire) +5.86%
Apr-08-24 07:15AM SAB Biotherapeutics to Present at INNODIA Annual Meeting (GlobeNewswire)
Apr-04-24 07:15AM SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-29-24 07:15AM SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results (GlobeNewswire)
Mar-25-24 10:15AM SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment (GlobeNewswire) -12.91%
Feb-23-24 08:00AM SAB Biotherapeutics to Present at the BIO CEO & Investor Conference (GlobeNewswire)
MMSC - First Trust Multi-Manager Small Cap Opportunities ETF - Stock Price Chart
TickerMMSC [NYSE]
CompanyFirst Trust Multi-Manager Small Cap Opportunities ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Factor & Thematic
Index-
TagsU.S., equity, growth, small-cap, Russell-2000
Sector/Theme Region
Dividend-Active/Passive
Total Holdings197AUM12.81M
Flows% 1M0.00%Flows% 3M43.31%
Flows% YTD30.25%Flows% 1Y
Return% 1Y30.25%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume7.10K52W Range14.15 - 20.33
DRMA - Dermata Therapeutics Inc - Stock Price Chart
TickerDRMA [NASD]
CompanyDermata Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.51MEPS (ttm)-32.72
P/E-EPS this Y59.63%
Forward P/E-EPS next Y71.49%
PEG-EPS past 5Y26.37%
P/S-EPS next 5Y-
P/B0.40EPS Q/Q79.29%
Dividend-Sales Q/Q-
Insider Own-Inst Own1.33%
Insider Trans-Inst Trans-
Short Float1.28%EarningsMay 15/a
Analyst Recom1.00Target Price10.00
Avg Volume11.46K52W Range3.48 - 38.55
May-17-24 08:30AM Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules (ACCESSWIRE) -19.23%
May-15-24 10:54PM DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q1 2024 (InvestorPlace)
04:05PM Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results (ACCESSWIRE)
May-13-24 07:23AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +5.94%
Apr-03-24 07:00AM Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now (GlobeNewswire)
Apr-02-24 07:00AM Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now (GlobeNewswire)
Mar-27-24 04:05PM Dermata to Present at the Emerging Growth Conference on April 3, 2024 (ACCESSWIRE)
Mar-21-24 10:53PM DRMA Stock Earnings: Dermata Therapeutics Reported Results for Q4 2023 (InvestorPlace)
04:05PM Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results (ACCESSWIRE)
Feb-07-24 07:00AM Presenting on the Emerging Growth Conference 67 Day 2 on February 8 Register Now (GlobeNewswire)
TBMC - Trailblazer Merger Corp I - Stock Price Chart
TickerTBMC [NASD]
CompanyTrailblazer Merger Corp I
CountryUSA
IndustryShell Companies
Market Cap97.24MEPS (ttm)0.22
P/E49.38EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.37EPS Q/Q249.10%
Dividend-Sales Q/Q-
Insider Own23.50%Inst Own71.56%
Insider Trans0.00%Inst Trans-
Short Float0.01%Earnings-
Analyst Recom-Target Price-
Avg Volume14.85K52W Range10.11 - 11.60
GTBP - GT Biopharma Inc - Stock Price Chart
TickerGTBP [NASD]
CompanyGT Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap7.68MEPS (ttm)-7.04
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y70.75%
P/S-EPS next 5Y-
P/B1.41EPS Q/Q-841.65%
Dividend-Sales Q/Q-
Insider Own10.42%Inst Own87.64%
Insider Trans0.00%Inst Trans-86.58%
Short Float0.47%EarningsMay 15/a
Analyst Recom1.00Target Price150.00
Avg Volume1.06M52W Range2.95 - 16.11
Today 09:15AM GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -30.64%
May-20-24 08:40AM Why Is GT Biopharma (GTBP) Stock Up 143% Today? (InvestorPlace) +150.00%
07:36AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
May-16-24 10:53AM GTBP Stock Earnings: GT Biopharma Beats EPS for Q1 2024 (InvestorPlace) +7.21%
May-15-24 05:00PM GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-26-24 09:53PM GTBP Stock Earnings: GT Biopharma Beats EPS for Q4 2023 (InvestorPlace)
05:00PM GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results (GlobeNewswire)
Feb-01-24 11:00AM GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split (GlobeNewswire) -6.16%
Dec-06-23 09:30AM Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote FOR All Proposed Items at the Upcoming Special Meeting of Stockholders (GlobeNewswire)
Dec-04-23 09:30AM GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia (GlobeNewswire) +6.91%
12345678⋯10⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.